• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经状态对乳腺 MRI 背景实质强化和纤维腺体组织的影响。

Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.

机构信息

Department of Radiology, Breast Imaging Section, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA.

出版信息

Eur Radiol. 2012 Dec;22(12):2641-7. doi: 10.1007/s00330-012-2553-8. Epub 2012 Jul 4.

DOI:10.1007/s00330-012-2553-8
PMID:22752463
Abstract

OBJECTIVE

To evaluate the effect of menopausal status on the background parenchymal enhancement (BPE) and amount of fibroglandular tissue (FGT) on breast MRI.

METHODS

Retrospective review identified 1,130 women who underwent screening breast MRI between July and November 2010. In 28 of these women, breast MRI was performed both at one time point while pre- and one time point while post-menopausal (median interval 49 months). Two independent readers blinded to menopausal status used categorical scales to rate BPE (minimal/mild/moderate/marked) and FGT (fatty/scattered/heterogeneously dense/dense). Consensus was reached when there was disagreement. The sign test was used to assess changes in rating categories, and the Spearman rank and Fisher's exact tests were used to measure correlations and associations between variables.

RESULTS

Significant proportions of women demonstrated decreases in BPE and FGT on post-menopausal breast MRI (P = 0.0001 and P = 0.0009). BPE category was unchanged in 39 % (11/28) and decreased in 61 % (17/28) of women. FGT category was unchanged in 61 % (17/28) and decreased in 39 % (11/28) of women. Age, reason for menopause, or interval between MRIs had no significant impact on changes in BPE and FGT.

CONCLUSION

On MRI, BPE, and FGT decrease after menopause in significant proportions of women; BPE decreases more than FGT.

KEY POINTS

On MRI, background parenchymal enhancement and fibroglandular tissue both decrease after menopause. The reduced postmenopausal enhancement is more marked in parenchyma than fibroglandular tissue. Background enhancement and fibroglandular tissue seen on MRI are under hormonal influence.

摘要

目的

评估绝经状态对乳腺 MRI 背景实质强化(BPE)和纤维腺体组织(FGT)量的影响。

方法

回顾性分析 2010 年 7 月至 11 月期间行乳腺 MRI 筛查的 1130 名女性。其中 28 名女性在同一时间点进行了绝经前和绝经后(中位间隔 49 个月)的乳腺 MRI 检查。两名独立的、对绝经状态不知情的读者使用分类量表对 BPE(轻度/中度/重度/明显)和 FGT(脂肪/散在/不均匀致密/致密)进行评分。当存在分歧时达成共识。使用符号检验评估评分类别的变化,使用 Spearman 秩和检验和 Fisher 精确检验测量变量之间的相关性和关联。

结果

绝经后乳腺 MRI 显示 BPE 和 FGT 显著减少(P=0.0001 和 P=0.0009)。BPE 分类在 39%(11/28)的女性中无变化,在 61%(17/28)的女性中减少。FGT 分类在 61%(17/28)的女性中无变化,在 39%(11/28)的女性中减少。年龄、绝经原因或 MRI 之间的间隔对 BPE 和 FGT 的变化没有显著影响。

结论

在 MRI 上,绝经后相当一部分女性的 BPE 和 FGT 减少;BPE 减少的程度大于 FGT。

关键点

在 MRI 上,背景实质强化和纤维腺体组织在绝经后都减少。绝经后增强的减少在实质中比纤维腺体组织更为明显。MRI 上看到的背景增强和纤维腺体组织受激素影响。

相似文献

1
Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.绝经状态对乳腺 MRI 背景实质强化和纤维腺体组织的影响。
Eur Radiol. 2012 Dec;22(12):2641-7. doi: 10.1007/s00330-012-2553-8. Epub 2012 Jul 4.
2
Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.芳香酶抑制剂对乳腺磁共振成像中背景实质强化和纤维腺体组织量的影响。
Radiology. 2012 Sep;264(3):670-8. doi: 10.1148/radiol.12112669. Epub 2012 Jul 6.
3
The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.双侧输卵管卵巢切除术对乳腺 MRI 背景实质增强和纤维腺体组织的影响。
Eur Radiol. 2014 Jan;24(1):162-8. doi: 10.1007/s00330-013-2993-9. Epub 2013 Aug 28.
4
Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.他莫昔芬对乳腺磁共振成像中纤维腺体组织、背景实质强化和囊肿数量的影响。
Breast J. 2012 Nov-Dec;18(6):527-34. doi: 10.1111/tbj.12002. Epub 2012 Sep 25.
5
Background parenchymal enhancement and fibroglandular tissue on breast MRI in women with high genetic risk: Are changes before and after risk-reducing salpingo-oophorectomy associated with breast cancer risk?背景实质强化和乳腺磁共振成像中高遗传风险女性的纤维腺体组织:降低风险的输卵管卵巢切除术前后的变化是否与乳腺癌风险相关?
Eur J Radiol. 2018 Dec;109:171-177. doi: 10.1016/j.ejrad.2018.10.030. Epub 2018 Nov 2.
6
Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.乳腺磁共振筛查项目中纤维-腺体组织(FGT)和背景实质强化(BPE)与乳腺癌风险和假阳性的关系:一项回顾性队列研究。
Eur Radiol. 2019 Sep;29(9):4678-4690. doi: 10.1007/s00330-019-06020-2. Epub 2019 Feb 22.
7
Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.使用磁共振扩散加权成像进行表观扩散系数图:背景实质强化、纤维腺体组织含量和绝经状态对乳腺癌诊断的影响。
Eur Radiol. 2018 Jun;28(6):2516-2524. doi: 10.1007/s00330-017-5202-4. Epub 2018 Jan 12.
8
Mammographic density, MRI background parenchymal enhancement and breast cancer risk.乳腺密度、MRI 背景实质增强与乳腺癌风险。
Ann Oncol. 2013 Nov;24 Suppl 8(Suppl 8):viii37-viii41. doi: 10.1093/annonc/mdt310.
9
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.乳腺 MRI 背景实质强化(BPE)的组织病理学特征。
Breast Cancer Res Treat. 2018 Nov;172(2):487-496. doi: 10.1007/s10549-018-4916-6. Epub 2018 Aug 23.
10
Background parenchymal enhancement at breast MR imaging and breast cancer risk.背景实质增强在乳腺磁共振成像和乳腺癌风险中的作用。
Radiology. 2011 Jul;260(1):50-60. doi: 10.1148/radiol.11102156. Epub 2011 Apr 14.

引用本文的文献

1
Detection of a contralateral breast malignancy using contrast-enhanced mammography (CEM) overlooked by initial MRI scan.利用对比增强乳腺钼靶摄影(CEM)检测出初始MRI扫描遗漏的对侧乳腺恶性肿瘤。
Radiol Case Rep. 2025 Jun 11;20(9):4275-4285. doi: 10.1016/j.radcr.2025.05.046. eCollection 2025 Sep.
2
Relationship between breast tissue involution and breast cancer.乳腺组织退化与乳腺癌之间的关系。
Front Oncol. 2025 Apr 7;15:1420350. doi: 10.3389/fonc.2025.1420350. eCollection 2025.
3
Hormonal Regulation of Background Parenchymal Enhancement at Contrast-enhanced Mammography.

本文引用的文献

1
Background parenchymal enhancement at breast MR imaging and breast cancer risk.背景实质增强在乳腺磁共振成像和乳腺癌风险中的作用。
Radiology. 2011 Jul;260(1):50-60. doi: 10.1148/radiol.11102156. Epub 2011 Apr 14.
2
Normal parenchymal enhancement patterns in women undergoing MR screening of the breast.女性乳腺磁共振筛查的正常实质增强模式。
Eur Radiol. 2011 Jul;21(7):1374-82. doi: 10.1007/s00330-011-2080-z. Epub 2011 Feb 17.
3
Screening breast MR imaging in women with a history of chest irradiation.对有胸部放疗史的女性进行乳腺磁共振成像筛查。
对比增强乳腺摄影中背景实质强化的激素调节
Radiology. 2025 Feb;314(2):e241158. doi: 10.1148/radiol.241158.
4
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity.霍奇金淋巴瘤幸存者的长期乳腺癌风险:评估背景实质强化和放疗诱导的毒性
Cancers (Basel). 2024 Dec 6;16(23):4091. doi: 10.3390/cancers16234091.
5
Increased background parenchymal enhancement on peri-menopausal breast magnetic resonance imaging.围绝经期乳腺磁共振成像中背景实质强化增加。
Eur J Radiol Open. 2024 Nov 18;13:100611. doi: 10.1016/j.ejro.2024.100611. eCollection 2024 Dec.
6
Asymmetric background parenchymal enhancement on contrast-enhanced mammography: associated factors, diagnostic workup, and clinical outcome.乳腺对比增强摄影中不对称性背景实质强化:相关因素、诊断检查及临床结局
Eur Radiol. 2025 Feb;35(2):712-722. doi: 10.1007/s00330-024-10856-8. Epub 2024 Jul 30.
7
Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.定量评估背景实质强化与筛查 MRI 中的乳腺癌终生风险相关。
Eur Radiol. 2024 Oct;34(10):6358-6368. doi: 10.1007/s00330-024-10758-9. Epub 2024 Apr 29.
8
Assessment of Background Parenchymal Enhancement at Dynamic Contrast-enhanced MRI in Predicting Breast Cancer Recurrence Risk.动态对比增强 MRI 背景实质强化评估预测乳腺癌复发风险。
Radiology. 2024 Jan;310(1):e230269. doi: 10.1148/radiol.230269.
9
Beyond Breast Density: Risk Measures for Breast Cancer in Multiple Imaging Modalities.超越乳腺密度:多种影像学模式下乳腺癌的风险评估指标。
Radiology. 2023 Mar;306(3):e222575. doi: 10.1148/radiol.222575. Epub 2023 Feb 7.
10
Obesity and metabolic dysfunction correlate with background parenchymal enhancement in premenopausal women.肥胖和代谢功能障碍与绝经前妇女的背景实质增强相关。
Obesity (Silver Spring). 2023 Feb;31(2):479-486. doi: 10.1002/oby.23649. Epub 2023 Jan 11.
Radiology. 2011 Apr;259(1):65-71. doi: 10.1148/radiol.10100991. Epub 2011 Feb 15.
4
Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.基线筛查乳腺 MRI 上的背景实质增强:对活检率和短期随访的影响。
AJR Am J Roentgenol. 2011 Jan;196(1):218-24. doi: 10.2214/AJR.10.4550.
5
Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia.托瑞米芬治疗经前乳痛的女性的乳腺磁共振成像结果
Acta Radiol. 2009 Nov;50(9):984-9. doi: 10.3109/02841850903168083.
6
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.雷洛昔芬对乳腺癌风险增加的绝经前女性乳房X线密度及乳腺磁共振成像的影响。
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1696-701. doi: 10.1158/1055-9965.EPI-07-2752. Epub 2008 Jun 26.
7
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.MRI上乳腺间质强化与新辅助化疗反应相关。
AJR Am J Roentgenol. 2008 Jun;190(6):1630-6. doi: 10.2214/AJR.07.2533.
8
Diagnostic breast MR imaging: current status and future directions.乳腺磁共振成像诊断:现状与未来方向
Radiol Clin North Am. 2007 Sep;45(5):863-80, vii. doi: 10.1016/j.rcl.2007.07.002.
9
Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations.绝经后女性的激素替代疗法:通过磁共振成像测定乳腺组织灌注——初步观察
Radiology. 2005 Apr;235(1):36-41. doi: 10.1148/radiol.2351040012.
10
Changes in magnetic resonance mammography due to hormone replacement therapy.激素替代疗法导致的乳腺磁共振成像变化。
Breast Cancer Res. 2004;6(3):R232-8. doi: 10.1186/bcr779. Epub 2004 Mar 16.